Julie C. Barnes PhD is Chief Scientific Officer at BioWisdom. Julie spent 15 years of her early career at GlaxoWellcome, now GlaxoSmithKline, where she held several senior positions including Head of Neuroscience. Her experience in pharmaceutical R&D includes project leadership across for early discovery through to the design of early Proof-of-Concept studies and biomarker development. At BioWisdom, Julie and her Healthcare team work with clients to support the BioWisdom’s Intelligence applications. Julie sits on the Board of BioWisdom, and holds invited positions on several other advisory boards of private companies and academic institutions

Link to BioWisdom here

The ERBI IT Special Interest Group is sponsored by